Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2008
07/24/2008US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
07/24/2008US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant
07/24/2008US20080175853 Virus-like particles for the induction of autoantibodies
07/24/2008US20080175847 Anti-dll4 antibodies and methods using same
07/24/2008US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases
07/24/2008US20080175842 Compositions and methods for treatment
07/24/2008US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies
07/24/2008US20080175840 Methods for treating angiogenesis related disorders
07/24/2008US20080175834 Carboxypertidase U (Cpu) Mutants
07/24/2008CA2675183A1 Apparatus and methods for osmotically shocking cells
07/24/2008CA2673765A1 Enhanced cell-free synthesis of active proteins containing disulfide bonds
07/24/2008CA2672091A1 Disintegrin variants and pharmaceutical uses thereof
07/23/2008EP1947201A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
07/23/2008EP1947187A1 Hybrid expression of neisserial proteins
07/23/2008EP1947185A1 HCV NS3/4A encoding nucleic acid
07/23/2008EP1947183A1 Mammalian cell surface antigens; related reagents
07/23/2008EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof
07/23/2008EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
07/23/2008EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent
07/23/2008EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
07/23/2008EP1947111A1 Novel mucin glycoprotein and use thereof
07/23/2008EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase
07/23/2008EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection
07/23/2008EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa
07/23/2008EP1945791A2 Expression of soluble factor viii proteins in bacteria
07/23/2008EP1945790A2 Vasoactive intestinal polypeptide pharmaceuticals
07/23/2008EP1945261A2 Compositions and methods for controlling tissue factor signaling specificity
07/23/2008EP1945257A2 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
07/23/2008EP1907419A4 Preparation of insulin conjugates
07/23/2008EP1573314B1 Transgenic mice expressing human cd20
07/23/2008EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule
07/23/2008EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
07/23/2008EP1270595B1 Anti ccr4 antibody and its fragment
07/23/2008EP1248841B1 Genes differentially expressed in breast cancer
07/23/2008EP1167537B1 Process for producing monoclonal antibody
07/23/2008EP1163271B1 Recombinant il-18 antibodies and their use
07/23/2008EP1155131B1 Vector comprising a splice acceptor trap and a poly a trap and the corresponding eukaryotic host cells
07/23/2008EP1068339B1 Compositions and methods for protein secretion
07/23/2008EP1032688B1 Single-chain bifunctional glycoprotein hormones
07/23/2008CN101228271A Method for bacillus coli to high effectively excrine representing lysostaphin
07/23/2008CN101227831A Method for enriching lignocellulose residues with yeast protein
07/23/2008CN101225426A Method for producing fish scale collagen by employing preservative agent
07/23/2008CN101225425A Process for preparing hypoglycemic active peptide by hydrolysis scabby grape protein
07/23/2008CN101225371A Preparation technology of recombinant human p43 protein
07/23/2008CN101225104A Method for preparing tilapia fishskin small molecular peptide chelate zinc salt
07/23/2008CN101225102A Method for preparing tilapia fishskin polypeptide chelate zinc salt
07/23/2008CN101225101A Preparation technology of promoting hepatocyte growth factor solution
07/23/2008CN100404684C Process for preparing high-purity amino acid and immune bioactive peptide
07/23/2008CN100404682C Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
07/23/2008CN100404677C Method for producing recombinant interleukin for animal
07/23/2008CN100404552C 因子Ⅷ多肽 Factor Ⅷ polypeptide
07/23/2008CN100404551C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
07/22/2008US7402730 Knockout animals manifesting hyperlipidemia
07/22/2008US7402729 Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
07/22/2008US7402728 Transgenic mice expressing human CD20 and/or CD16
07/22/2008US7402667 Promoter, promoter control elements, and combinations, and uses thereof
07/22/2008US7402662 Antibody molecules specific to human tumor necrosis factor alpha
07/22/2008US7402661 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/22/2008US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein
07/22/2008US7402659 Recombinant cytokine for diagnosis, prevention and treatment of tissue-degenerating disorders
07/22/2008US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family
07/22/2008US7402657 C-C chemokine receptor 3 proteins
07/22/2008US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders
07/22/2008US7402565 Processes for making acylated insulin
07/22/2008US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells
07/22/2008US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine)
07/22/2008US7402419 Oxidoreductase comprising enhanced thermostability for use as nicotinamide adenine dinucleotide phosphate regenerative tool
07/22/2008US7402417 P450 oxygenases and methods of use
07/22/2008US7402412 Nucleotide sequence encoding protein which hybridizes to another DNA; monatin produced from 4-(indol-3-ylmethyl)-4-hydroxy-2-oxoglutaric
07/22/2008US7402410 Humanized immunoglobulin reactive with α4β7 integrin
07/22/2008US7402409 Cell fusion method
07/22/2008US7402407 Chemically targeted positional identification of post-translationally phosphorylated peptides
07/22/2008US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
07/22/2008US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines
07/22/2008US7402314 Antigen peptides; medical diagnosis
07/22/2008US7402310 Deoxyribonuclease, gene encoding same and use thereof
07/22/2008US7402309 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions
07/22/2008US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders
07/22/2008US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders
07/22/2008US7402303 Chemokine mutants in the treatment of multiple sclerosis
07/22/2008CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods
07/22/2008CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto
07/22/2008CA1341577C Expression of biologically active factor xiii
07/17/2008WO2008086466A1 Enzyme production in culture medium comprising raw glycerol
07/17/2008WO2008085551A2 Smallpox monoclonal antibody
07/17/2008WO2008085356A1 Conditioning biomass for microbial growth
07/17/2008WO2008083493A1 Stabilization of cyclic peptide structures
07/17/2008WO2008083453A1 Process to produce biomass and proteins by microalgae
07/17/2008WO2008033477A3 Antimicrobial activity in variants of lacritin
07/17/2008WO2007145806A3 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
07/17/2008US20080172764 Axmi-004, a delta-endotoxin gene and methods for its use
07/17/2008US20080171855 Polyvalent protein complex
07/17/2008US20080171702 Novel gene and uses therefor
07/17/2008US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors;
07/17/2008US20080171363 Interferon-alpha polypeptides and conjugates
07/17/2008US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity
07/17/2008US20080171360 Carbohydrate active hydrolase; biomass conversion for biofuels; ethanol production; enhancing feed compositions and food processing
07/17/2008US20080171359 Using transgenic yarrowia as bioreactor for use in production of epoxide hydrolase; generating vicinal diols for use as chemical intermediates for the production of pharmaceuticals, agrochemicals, ferro-electric liquid crystals flavors and fragrances
07/17/2008US20080171358 Expression System
07/17/2008US20080171357 Using escherichia as bioreactor for production of empedobacter or sphingobacterium peptide sequences for use in pharmaceutical and foods